Ayaahuasca Drug Trialed for Addiction

This is a news story, published by Guardian, that relates primarily to University College London news.

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

Guardian news

For more news from Guardian, you can click here:

more news from Guardian

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

psychedelics research

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest powerful psychoactive substances news, ayahuasca news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

powerful psychedelic

Guardian

•

Psychedelic drug DMT trialled on patients to treat alcohol addiction

Summary

Nutrition label

70% Informative

Dimethyltryptamine (DMT) is the active ingredient in ayahuasca, a hallucinogenic brew that has been used for thousands of years by shamans in South America .

Scientists based at University College London are testing whether a one -off dose of the drug could help hazardous drinkers who want to reduce their alcohol intake.

VR Score

Informative language

Neutral language

Article tone

informal

Language

English

Language complexity

Offensive language

possibly offensive

Hate speech

not hateful